Last updated on June 2018

Phase III Study of Idasanutlin

Brief description of study

People with Relapsed/Refractory Acute Myeloid Leukemia are asked to participate in a research study being conducted by Northwell Health.

Clinical Study Identifier: TX200742

Contact Investigators or Research Sites near you

Start Over

Carolyn Pellizzari, Study Coordinator

Biomedical Research Alliance of New York
Lake Success, NY USA
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.